Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome

Blood

Volumn 95, Issue 1, 2000, Pages 90-95

  Tallman, Martin S ^a   Andersen, Janet W ^b   Schiffer, Charles A ^b   Appelbaum, Frederick R ^b   Feusner, James H ^b   Ogden, Angela ^b   Shepherd, Lois ^b   Rowe, Jacob M ^b   François, Christopher ^b   Larson, Richard S ^b   Wiernik, Peter H ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE COURSE; FEMALE; HUMAN; INFANT; LEUKOCYTE COUNT; MALE; OUTCOMES RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; RETINOIC ACID SYNDROME; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; FEMALE; FEVER; GLUCOCORTICOIDS; HUMANS; INCIDENCE; INFANT; LEUKEMIA, PROMYELOCYTIC, ACUTE; LUNG; MALE; MIDDLE AGED; PERICARDIAL EFFUSION; PLEURAL EFFUSION; REMISSION INDUCTION; RESPIRATORY DISTRESS SYNDROME, ADULT; SYNDROME; TRETINOIN; WEIGHT GAIN;

EID: 0033975849     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Fenaux P, Le Deley MC, Castaigne S, et al. Effect of all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia: results of a multicenter randomized trial. Blood. 1993;82:3241-3249.
2. Tallman MS, Andersen JW, Schiffer CA, et al. Alltrans retinoic acid in acute promyelocytic leukemia. N Engl J Med. 1997;337:1021-1028.
3. Frankel SR, Eardley A, Lawers G, Weiss M, Warrell RP. The "retinoic acid syndrome" in acute promyelocytic leukemia. Ann Intern Med. 1992;117: 292-296.
4. Castaigne S, Chomienne C, Daniel MT, et al. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood. 1990;76:1704-1709.
5. Warrell RP, Frankel SR, Miller WH Jr, et al. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med. 1991;324:1385-1393.
6. Vahdat L, Maslak P, Miller WH Jr, et al. Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PML-RARα isoform, and CD13 expression in patients with all-trans retinoic acid. Blood. 1994;84:3843-3849.
7. Seale J, Delva L, Renesto P, et al. All-trans retinoic acid rapidly decreases cathepsin G synthesis and mRNA expression in acute promyelocytic leukemia. Leukemia. 1996;10:95-101.
8. Di Noto R, Schiavone EM, Ferrara F, Manzo C, Lo Pardo C, Del Vecchio L. All-trans ratinoic acid promotes a differential regulation of adhesion molecules on acute myeloid blast cells. Br J Haematol. 1996;88:247-255.
9. Di Noto R, Schiavone EM, Ferrara F, Manzo C, Lo Pardo C, Del Vecchio L. Expression and ATRA-driven modulation of adhesion molecules in acute promyelocytic leukemia. Leukemia. 1994;8(suppl 2):S71-S76.
10. Dubois C, Schlageter MH, de Gentile A, et al. Modulation of IL-8, IL-1β, and G-CSF secretion by all-trans retinoic acid in acute promyelocytic leukemia. Leukemia. 1994;8:1750-1757.
11. 4. Br J Haematol. 1996;93:360-366.
12. 4 by utilization of LFA-1 and ICAM-2. Blood. 1997;90:2747-2756.
13. De Botton S, Dombret H, Sanz M, et al. Incidence, clinical features, and outcome of all-trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. Blood. 1998;92:2712-2718.
14. Smith-Whitley K, Lange B. Fatal all-trans retinoic acid pneumonitis [letter]. Ann Intern Med. 1993; 118:472.
15. Wiley JS, Firkin FC. Reduction of pulmonary toxicity by prednisolone prophylaxis during all-trans retinoic acid treatment of acute promyelocytic leukemia. Leukemia. 1995;9:774-778.
16. Fenaux P, Chastang C, Sanz M, et al. A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed APL. Blood. 1999;94: 1192-1200.
17. Avvisati G, Lo Coco F, Diverio D, et al. AIDA (All-trans retinoic acid plus idarubicin) in newly diagnosed acute promyelocytifc leukemia: a GIMEMA pilot study. Blood. 1996;88:1390-1398.
18. Mandelli F, Diverio D, Avvisati G, et al. Molecular remission in PML/RARα-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Blood. 1997;90: 1014-1021.
19. Asou N, Adachi K, Tamura J, et al. Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. J Clin Oncol. 1997;16: 78-85.
20. Gallagher RE, Willman CL, Slack JL, et al. Association of PML/RARα fusion mRNA type with pretreatment hematologic characteristics, but not treatment outcome in acute promyelocytic leukemia. An intergroup molecular study. Blood. 1997; 90:1656-1663.
21. Fenaux P, Castaigne S, Chomienne C, Dombret H, Degos L. All-trans retinoic acid treatment for patient with acute promyelocytic leukemia. Leukemia. 1992;6(suppl 1):64-66.
22. Silberschmid M, Lund C. Lung fraction and morphology after hemorrhagic shock, soft tissue trauma and regional ischemia in dogs. Eur Surg Res. 1978;10:404-414.
23. McLaughlin JD, Leellacer R, Attar S, Cowley RA. The lung in trauma. Amer Surg. 1970;36:157-162.
24. Clowes G, Hirsch E, Williams L, et al. Septic lung and shock in man. Ann Surg. 1975;181:681-692.
25. Corrin B. Lung pathology in septic shock. J Clin Pathol. 1980;33:891-894.
26. Fallat R, Mielke C, Rodvien R. Adult respiratory distress syndrome and gram-negative sepsis: a deadly duo. Arch Intern Med. 1980;140:612-613.
27. Feng D, Nagy JA, Pyne K, Dvorak HF, Dvorak AM. Neutrophils emigrate from venules by a transendothelial cell pathway in response to fMLP. J Exp Med. 1998;189:903-915.
28. McKee LC, Collins RD. Intravascular leukocyte thrombi and aggregates as a cause of morbidity and mortality in leukemia. Medicine. 1994;53:463-478.
29. 2) in acute promyelocytic leukemia. Blood. 1993;82:3560-3563.
30. Chen GQ, Shen ZX, Wu F, et al. Pharmacokinetics and efficacy of low-dose all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Leukemia. 1996;10:825-828.
31. Miller VA, Rigas JR, Benedetti FM, et al. Initial clinical trials of the retinoid receptor panagonist 9-cis retinoic acid. Clin Cancer Res. 1996;2:471-475.
32. Tobita T, Takeshita A, Kitamura K, et al. Treatment with a new synthetic retinoid, Am80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid. Blood. 1997;90:967-973.